How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
77
HALO Quote, Financials, Valuation and Earnings
Last price:
$63.78
Seasonality move
:
3.37%
Day range:
$62.60 - $64.07
52-week range:
$37.73 - $66.00
Dividend yield:
0%
P/E ratio:
18.60x
P/S ratio:
8.13x
P/B ratio:
21.60x
Volume:
1.6M
Avg. volume:
1.5M
1-year change:
56.86%
Market cap:
$7.9B
Revenue:
$1B
EPS (TTM):
$3.43
Earnings Data
Next earnings date for HALO
May 07
2025
Most recent earnings per share
$1.06
Missed by $0.10
(Feb 18/2025)
Consensus Estimate
$1.16
(Feb 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HALO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $279.6M | -- | -- | $1.14 | -- |
| 05/07/2025 | Q1 | $231.2M | -- | -- | $0.96 | -- |
| 02/18/2025 | Q4 | $285.7M | $298M | $1.06 | $1.16 | -$0.10 |
| 10/31/2024 | Q3 | $252.2M | $290.1M | $1.05 | $1.00 | $0.05 |
| 08/06/2024 | Q2 | $204.9M | $231.4M | $0.72 | $0.76 | -$0.04 |
| 05/07/2024 | Q1 | $199.6M | $195.9M | $0.60 | $0.70 | -$0.10 |
| 02/20/2024 | Q4 | $231.1M | $230M | $0.65 | $0.83 | -$0.18 |
| 11/06/2023 | Q3 | -- | -- | $0.61 | $0.71 | -$0.10 |
| 08/08/2023 | Q2 | -- | -- | $0.56 | $0.64 | -$0.08 |
| 05/09/2023 | Q1 | -- | -- | $0.29 | $0.48 | -$0.19 |
| 02/21/2023 | Q4 | -- | -- | $0.42 | $0.47 | -$0.05 |
| 11/08/2022 | Q3 | -- | -- | $0.44 | $0.51 | -$0.07 |
| 08/09/2022 | Q2 | -- | -- | $0.16 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | $0.43 | -- | -- |
| 02/22/2022 | Q4 | -- | -- | $0.46 | -- | -- |
| 11/02/2021 | Q3 | -- | -- | $1.48 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | $0.62 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | $0.19 | -- | -- |
| 02/23/2021 | Q4 | -- | -- | $0.50 | -- | -- |
| 11/02/2020 | Q3 | -- | -- | $0.25 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | $0.19 | -- | -- |
| 05/11/2020 | Q1 | -- | -- | -$0.04 | -- | -- |
| 02/24/2020 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$0.17 | -- | -- |
| 08/06/2019 | Q2 | -- | -- | -$0.10 | -- | -- |
| 05/07/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 02/21/2019 | Q4 | -- | -- | -$0.01 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.16 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
| 02/20/2018 | Q4 | -- | -- | $0.85 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | $0.02 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.26 | -- | -- |
| 02/28/2017 | Q4 | -- | -- | -$0.21 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.23 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.21 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.16 | -- | -- |
| 02/29/2016 | Q4 | -- | -- | $0.03 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/10/2015 | Q2 | -- | -- | $0.02 | -- | -- |
Halozyme Therapeutics Earnings Questions
-
How Much did Halozyme Therapeutics Generate in Revenue Last Quarter?
Halozyme Therapeutics reported $298M worth of top line sales in its most recent quarter.
-
Did Halozyme Therapeutics Beat Earnings Last Quarter?
Halozyme Therapeutics announced earnings per share of $1.06 which represents a miss of analyst forecast a $1.16 per share.
-
Is Halozyme Therapeutics Profitable?
Halozyme Therapeutics reported $256M that represents $1.98 per share over the last quarter.
-
What is the Analyst Consensus for Halozyme Therapeutics EPS Next Year?
Halozyme Therapeutics's earnings are forecast to grow from $3.43 per share to $4.13 per share next year representing an increase of 42.93%.
-
When is Halozyme Therapeutics's Earnings Date?
Halozyme Therapeutics's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 12.45% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 3.2% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 2.38% over the past day.
